Last reviewed · How we verify
NCT01475617
Efficacy of a Novel Multivitamin-Mineral Supplement in Preventing Vitamin Deficiency in Postoperative Bariatric Patients
Phase 2/Phase 3 trial testing AquaVanta Chewable Tablet in Bariatric Surgery Candidate in 61 participants. Completed in 1 June 2014.
1 January 2014
Quick facts
| Lead sponsor | Yasoo Health |
|---|---|
| Phase | Phase 2/Phase 3 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 61 |
| Start date | 1 November 2011 |
| Primary completion | 1 January 2014 |
| Estimated completion | 1 June 2014 |
| Sites | 1 location across United States |
Drugs / interventions tested
- AquaVanta Chewable Tablet
- Flinstones Complete
- Nature Made Calcium Softgels
- Nature Made Calcium Softgels
- Twin Labs Iron Caps
- Rexall Vitamin B12 Tablet
Conditions studied
- Bariatric Surgery Candidate — all drugs for Bariatric Surgery Candidate →
Sponsor
Yasoo Health
Who can join
Adults 18 to 65, any sex, with Bariatric Surgery Candidate. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Plasma vitamin and mineral levels
Time frame: 3 and 6 months compared to baseline
Sponsor's own description
Approximately 33% of the US adult population can be classified as obese based on body mass index. This epidemic of obesity has resulted in over 200,000 bariatric surgeries performed every year for the treatment of "clinically severe obesity". Roux-en-Y gastric bypass (RYGB) is the most common bariatric procedure performed in the United States and has both restrictive and malabsorptive components. Despite the success of this procedure in creating long lasting weight loss, vitamin and iron deficiencies are common and can lead to significant morbidity if not appropriately addressed. Despite the American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic \& Bariatric Surgery Medical Guidelines that include vitamin and mineral supplementation recommendations, there has been very little prospective research conducted to assess the efficacy and compliance of these micronutrient interventions. This prospective randomized controlled clinical study will evaluate the efficacy of a novel vitamin/mineral supplement in decreasing micronutrient deficiencies in post operative bariatric patients.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A Randomized Trial of a Novel Chewable Multivitamin and Mineral Supplement Following Roux-en-Y Gastric Bypass.
Perin J, Prokopowicz G, Furtado M, Papas K, et al · · 2018 · cited 11× · PMID 29500675 · DOI 10.1007/s11695-018-3177-0
Verify or expand the search:
- PubMed search for NCT01475617
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Bariatric Surgery Candidate
Currently open trials in the same condition.
- NCT07525232 — Stepwise PEEP vs Sustained Inflation in Bariatric Surgery Patients · NA · recruiting
- NCT06511310 — Exercise, Brain Activity, and Weight Maintenance · NA · recruiting
- NCT05966727 — Exploratory Evaluation of the Effect of Cholestyramine on Serum Levels of POPs in Obese Female Patients · NA · recruiting
- NCT06915558 — Modulation of the Inflammatory Response in Bariatric Surgery · recruiting
- NCT06689241 — Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric Surgery · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01475617 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Yasoo Health
- Last refreshed: 20 January 2015
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01475617.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing